{'fraction_non_alphanumeric': 0.03389830508474576, 'fraction_numerical': 0.024771838331160364, 'mean_word_length': 5.453781512605042, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
An Endovascular Approach to Cardioembolic Stroke Prevention in Atrial Fibrillation Patients

This report is of a 62‐year‐old woman presenting with a 3‐year history of chronic atrial fibrillation (AF) and unable to tolerate chronic warfarin therapy due to bleeding episodes and unstable INR values. Additional high risk factors for stroke are a history of congestive heart failure and previous embolic stroke. Percutaneous left atrial appendage transcatheter occlusion (PLAATO™) was performed to seal the LAA. A transesophageal echocardiography (TEE) at the 1‐ and 6‐month follow‐up showed no device migration and no new thrombus related to the implant. The patient has been doing well on postprocedure aspirin with no embolic events. (PACE 2003; 26[Pt. II]:1604–1606)